548 results on '"Schaapveld, M."'
Search Results
2. Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphoma
3. Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphoma
4. Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphoma
5. Comparing causes of death of Hodgkin lymphoma and breast cancer patients between medical records and cause-of-death statistics
6. Development and Validation of Risk Prediction Models for Coronary Heart Disease and Heart Failure After Treatment for Hodgkin Lymphoma
7. Association of Radiation and Procarbazine Dose With Risk of Colorectal Cancer Among Survivors of Hodgkin Lymphoma.
8. Cardiovascular Disease in Testicular Cancer Survivors: Identification of Risk Factors and Impact on Quality of Life.
9. Cause-specific excess mortality in patients treated for cancer of the oral cavity and oropharynx: A population-based study
10. The epidemiology of head and neck squamous cell carcinoma in The Netherlands during the era of HPV-related oropharyngeal squamous cell carcinoma. Is there really evidence for a change?
11. Prognostic value of insulin-like growth factor 1 and insulin-like growth factor binding protein 3 blood levels in breast cancer
12. Employment and social benefits up to 10 years after breast cancer diagnosis: a population-based study
13. Clinicopathological features and risk factors for developing colorectal neoplasia in Hodgkin's lymphoma survivors
14. Breast cancer and cardiovascular outcomes after breast cancer in survivors of Hodgkin lymphoma
15. OC-0295 Colorectal cancer risk following radiotherapy and procarbazine for Hodgkin lymphoma
16. Supplement to: Second cancer risk up to 40 years after treatment for Hodgkinʼs lymphoma.
17. A randomized phase II study investigating the addition of the specific COX-2 inhibitor celecoxib to docetaxel plus carboplatin as first-line chemotherapy for stage IC to IV epithelial ovarian cancer, Fallopian tube or primary peritoneal carcinomas: the DoCaCel study
18. Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe
19. Effect of hospital characteristics on outcome of patients with gastric cancer: A population based study in North-East Netherlands
20. Long-Term Risk of Skin Cancer Among Childhood Cancer Survivors: A DCOG-LATER Cohort Study
21. Melanoma risk after ovarian stimulation for in vitro fertilization
22. Cancer in adolescents and young adults in north Netherlands (1989–2003): increased incidence, stable survival and high incidence of second primary tumours
23. Long-Term Risk of Ovarian Cancer and Borderline Tumors After Assisted Reproductive Technology
24. Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients
25. Pathologic response of ductal carcinoma in situ to neoadjuvant systemic treatment in HER2-positive breast cancer
26. Dose-Dependent Effect of Platinum-Based Chemotherapy on the Risk of Metachronous Contralateral Testicular Cancer
27. Risk of breast cancer in women after a salivary gland carcinoma or pleomorphic adenoma in the Netherlands
28. Implementation of trastuzumab in conjunction with adjuvant chemotherapy in the treatment of non-metastatic breast cancer in the Netherlands
29. Platinum exposure and cause-specific mortality among patients with testicular cancer
30. Time Trends and Prognostic Factors for Overall Survival in Myxoid Liposarcomas: A Population-Based Study
31. Risk of breast cancer in women after a salivary gland carcinoma or pleomorphic adenoma in the Netherlands
32. Prognosis of acute coronary syndromes after radiotherapy for breast cancer
33. Prognosis of acute coronary syndromes after radiotherapy for breast cancer
34. Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma
35. Risk of subsequent in situ and invasive lesions after a primary diagnosis of ductal carcinoma in situ with follow-up time up to 28 years
36. Non-intervention vs. surgical interventions in (Low-Risk) Ductal Carcinoma In Situ: A DCIS multi-state model for decision analytics
37. Randomised Phase III study of biweekly 24-h infusion of high-dose 5FU with folinic acid and oxaliplatin versus monthly plus 5-FU/folinic acid in first-line treatment of advanced colorectal cancer
38. Safety and cost-effectiveness of shortening hospital follow-up after breast cancer treatment
39. Incidence of metachronous contralateral testicular germ cell tumour and association with chemotherapy
40. Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase protein expression on survival in adjuvantly treated stage III colon cancer patients
41. Pulmonary tumours in the Netherlands: focus on temporal trends in histology and stage and on rare tumours
42. Radiation Dose-Response for Risk of Myocardial Infarction in Breast Cancer Survivors
43. Risk factors for upgrading and upstaging of pre-operative biopsies in ductal carcinoma in situ
44. High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with >= 4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study
45. No association between the Arg201Gly polymorphism of the DCC gene and colorectal cancer
46. Long-Term Risk of Skin Cancer Among Childhood Cancer Survivors: A DCOG-LATER Cohort Study
47. Overall and disease-specific survival of Hodgkin lymphoma survivors who subsequently developed gastrointestinal cancer
48. Re: Risk of solid cancer after treatment of testicular germ cell cancer in the platinum era
49. Radiation Dose-Response for Risk of Myocardial Infarction in Breast Cancer Survivors
50. Re: Risk of solid cancer after treatment of testicular germ cell cancer in the platinum era
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.